Latest Regulatory Framework News

Rimfire Pacific Mining Limited has had its trading suspension lifted immediately following the release of its capital raising results, signaling renewed market activity.

Infinity Lithium progresses its Australian gold-copper-silver exploration with new option agreements, while facing delays and strategic shifts in its Spanish lithium project.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

Bio-Gene Technology Limited has completed the second tranche of its share placement, securing approximately A$2.46 million and issuing unlisted options to investors and its lead manager.

Australian Rare Earths (ASX, AR3) has responded to an ASX price query, denying any undisclosed price-sensitive information and attributing recent trading activity to sector interest and recent company announcements.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

Australian Bond Exchange Holdings has joined a Reserve Bank of Australia-led pilot exploring atomic settlement of tokenised bonds using digital currencies, aiming to transform bond market infrastructure.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Pioneer Lithium has expanded its uranium portfolio in Namibia through the acquisition of the Gaobis Uranium Project, adding significant prospective ground adjacent to its Warmbad Project. This move positions the company to accelerate uranium resource growth in a globally important mining jurisdiction.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.

Laramide Resources has expanded its private placement to raise up to $12 million, aiming to fast-track US permitting and strengthen its balance sheet. The move signals confidence in advancing its late-stage uranium projects amid a competitive market.

Netlinkz Limited reports $2.4 million in quarterly receipts and announces a strategic joint venture in the Philippines, enhancing its cybersecurity footprint in the ASEAN region with innovative network solutions.